Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 5, 2016, Pages 1339-1344

  Kuipers, Hedwich F ^a,b   Rieck, Mary ^a   Gurevich, Irina ^b   Nagy, Nadine ^a   Butte, Manish J ^b   Negrin, Robert S ^a   Wight, Thomas N ^c   Steinman, Lawrence ^b   Bollyky, Paul L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Astrogliosis; Hyaluronan; Multiple sclerosis; T cell polarization; T cell trafficking

Indexed keywords

HYALURONIC ACID; HYMECROMONE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CARBOHYDRATE SYNTHESIS; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE MODEL; NONHUMAN; PARENCHYMA; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL POLARITY; IMMUNOLOGY;

ANIMALS; CELL POLARITY; HYALURONIC ACID; HYMECROMONE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 84956677725     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1525086113     Document Type: Article

References (49)

1. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359(9313):1221-1231.
2. Steinman L (2014) Immunology of relapse and remission in multiple sclerosis. Annu Rev Immunol 32:257-281.
3. Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91(1):221-264.
4. Laurent TC, Laurent UB, Fraser JR (1996) The structure and function of hyaluronan: An overview. Immunol Cell Biol 74(2):A1-A7.
5. Termeer C, et al. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195(1):99-111.
6. Jiang D, et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11(11):1173-1179.
7. Bollyky PL, et al. (2010) Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse. Cell Mol Immunol 7(3):211-220.
8. Bollyky PL, Bogdani M, Bollyky JB, Hull RL, Wight TN (2012) The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep 12(5):471-480.
9. Bogdani M, et al. (2014) Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes 63(8):2727-2743.
10. Yoshioka Y, et al. (2013) Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts. Arthritis Rheum 65(5):1160-1170.
11. McKee CM, et al. (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98(10):2403-2413.
12. Scheibner KA, et al. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177(2):1272-1281.
13. Jiang D, Liang J, Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435-461.
14. Back SA, et al. (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11(9):966-972.
15. Asher R, Perides G, Vanderhaeghen JJ, Bignami A (1991) Extracellular matrix of central nervous system white matter: Demonstration of an hyaluronate-protein complex. J Neurosci Res 28(3):410-421.
16. Struve J, et al. (2005) Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. Glia 52(1):16-24.
17. Cargill R, et al. (2012) Astrocytes in aged nonhuman primate brain gray matter synthesize excess hyaluronan. Neurobiol Aging 33(4):830.e13-830.e24.
18. Winkler CW, et al. (2012) Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitis. J Biol Chem 287(40):33237-33251.
19. Nagy N, et al. (2015) 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 6:123.
20. Kakizaki I, et al. (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279(32):33281-33289.
21. Kultti A, et al. (2009) 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315(11):1914-1923.
22. Mueller AM, Yoon BH, Sadiq SA (2014) Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS. J Biol Chem 289(33):22888-22899.
23. Lio C-WJ, Hsieh C-S (2008) A two-step process for thymic regulatory T cell development. Immunity 28(1):100-111.
24. Burchill MA, et al. (2008) Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28(1):112-121.
25. Guan H, Nagarkatti PS, Nagarkatti M (2009) Role of CD44 in the differentiation of Th1 and Th2 cells: CD44-deficiency enhances the development of Th2 effectors in response to sheep RBC and chicken ovalbumin. J Immunol 183(1):172-180.
26. Guan H, Nagarkatti PS, Nagarkatti M (2011) CD44 reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J Immunol 186(12):6955-6964.
27. Nagy N, et al. (2015) Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J Clin Invest 125(10):3928-3940.
28. Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN (2012) Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol 31(2):90-100.
29. De Grendele HC (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278(5338):672-675.
30. Brennan FR, et al. (1999) CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 98(3):427-435.
31. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T (1999) Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA 96(12):6896-6901.
32. Nandi A, Estess P, Siegelman MH (2000) Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 275(20):14939-14948.
33. Flynn KM, Michaud M, Madri JA (2013) CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: A role in immune cells and vascular cells of the blood-brain barrier. Am J Pathol 182(4):1322-1336.
34. Chabas D, et al. (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294(5547):1731-1735.
35. Hur EM, et al. (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8(1):74-83.
36. Cook AC, Chambers AF, Turley EA, Tuck AB (2006) Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J Biol Chem 281(34):24381-24389.
37. Tajima K, et al. (2010) Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene 29(13):1941-1951.
38. Marroquin CE, Downey L, Guo H, Kuo PC (2004) Osteopontin increases CD44 expression and cell adhesion in RAW 264. 7 murine leukemia cells. Immunol Lett 95(1):109-112.
39. Zhang F-J, et al. (2013) The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol Int 33(1):79-83.
40. Park JB, Kwak H-J, Lee S-H (2008) Role of hyaluronan in glioma invasion. Cell Adhes Migr 2(3):202-207.
41. Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7(4):494-506.
42. Miljkovic D, Timotijevic G, Mostarica Stojkovic M (2011) Astrocytes in the tempest of multiple sclerosis. FEBS Lett 585(23):3781-3788.
43. Haegel H, Tölg C, Hofmann M, Ceredig R (1993) Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 122(5):1067-1077.
44. Dzwonek J, Wilczynski GM (2015) CD44: Molecular interactions, signaling and functions in the nervous system. Front Cell Neurosci 9:175.
45. Mayo L, et al. (2014) Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med 20(10):1147-1156.
46. Toft-Hansen H, Füchtbauer L, Owens T (2011) Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59(1):166-176.
47. Nagy N, et al. (2010) Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: Novel insights into the role of hyaluronan synthesis. Circulation 122(22):2313-2322.
48. Cao Y-A, et al. (2004) Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci USA 101(1):221-226.
49. Maynard CL, etal. (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 8(9):931-941.